ArriVent BioPharma, Inc. (AVBP) stock
AVBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.90+0.21 (+1.96%)
Close on Nov 18, 2026Market cap $537.45MP/E –Yield –
ArriVent BioPharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
ArriVent BioPharma's market cap was $652.56M on Nov 11, 2026, against $937.15M a year earlier. Over the last 3 years it ranged from $45.36M to $1.57B, with a median of $795.82M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $652.56M | -20.6% |
| 2025 | Dec 31, 2025 | $821.95M | -8.4% |
| 2024 | Dec 31, 2024 | $897.62M | – |
See a number that looks wrong?